Freedom Investment Management’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-37,557
| Closed | -$54K | – | 856 |
|
|
2016
Q1 | $54K | Sell |
37,557
-8,345
| -18% | -$12K | ﹤0.01% | 809 |
|
|
2015
Q4 | $75K | Buy |
45,902
+36,577
| +392% | +$59.8K | 0.01% | 760 |
|
|
2015
Q3 | $832K | Sell |
9,325
-36,398
| -80% | -$3.25M | 0.08% | 197 |
|
|
2015
Q2 | $125K | Sell |
45,723
-3,668
| -7% | -$10K | 0.01% | 652 |
|
|
2015
Q1 | $165K | Sell |
49,391
-6,328
| -11% | -$21.1K | 0.02% | 600 |
|
|
2014
Q4 | $193K | Buy |
55,719
+39,395
| +241% | +$136K | 0.03% | 546 |
|
|
2014
Q3 | $82K | Buy |
16,324
+781
| +5% | +$3.92K | 0.01% | 485 |
|
|
2014
Q2 | $215K | Buy |
15,543
+419
| +3% | +$5.8K | 0.04% | 442 |
|
|
2014
Q1 | $232K | Buy |
15,124
+2,203
| +17% | +$33.8K | 0.05% | 355 |
|
|
2013
Q4 | $104K | Buy |
12,921
+982
| +8% | +$7.9K | 0.03% | 419 |
|
|
2013
Q3 | $119K | Buy |
+11,939
| New | +$119K | 0.03% | 357 |
|